Literature DB >> 8917876

The prevalence and direct costs of pre-immunization testing for hepatitis A in general practice.

D Buckley1, T Fahey, G Bevan.   

Abstract

Two hundred and twenty patients in one general practice travelling to destinations where immunization against hepatitis A virus (HAV) is recommended were tested for their HAV immune status before immunization. Age-specific prevalence of prior immunity to HAV was estimated. The relative costs of pre-immunization testing and immediate immunization were compared. The most cost-effective testing method for this practice was found to be total population testing prior to immunization with HAV vaccine. Individual general practices can estimate the optimal age at which to commence testing for HAV in their own practice population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917876      PMCID: PMC1239752     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  4 in total

1.  Not all travellers need immunoglobulin for hepatitis A.

Authors:  J H Cossar; D Reid
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

2.  Prophylaxis against hepatitis A for travel.

Authors:  P Moore; P Oakeshott; J Logan; J Law; D M Harris
Journal:  BMJ       Date:  1990-03-17

3.  Epidemiology and prevention of hepatitis A in travelers.

Authors:  R Steffen; M A Kane; C N Shapiro; N Billo; K J Schoellhorn; P van Damme
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

4.  Age-specific antibody prevalence to hepatitis A in England: implications for disease control.

Authors:  N J Gay; P Morgan-Capner; J Wright; C P Farrington; E Miller
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.